Clinical Trial Update: Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating defibrotide for the treatment of severe hepatic veno-occlusive disease in hematopoietic stem cell transplant patients has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Veno-occlusive Disease

Drugs mentioned

• Defibrotide (defibrotide)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Severe Hepatic Veno-Occlusive Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-01-30